Treatment of Helicobacter pylori Infection 2015. (Q38587356)

4 September 2017

Treatment of Helicobacter pylori Infection 2015. (English)

1 reference

Helicobacter pylori infectious disease

4 September 2017

1 reference

1 reference

4

Spiros Ladas

1 reference

4 September 2017

Anthony O'Connor

1

1 reference

PubMed ID

26372826

4 September 2017

Javier P Gisbert

series ordinal

2

1 reference

PubMed ID

26372826

4 September 2017

Colm O'Morain

series ordinal

3

1 reference

4 September 2017

1 September 2015

1 reference

4 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Helicobacter

1 reference

4 September 2017

20 Suppl 1

1 reference

4 September 2017

54-61

1 reference

Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis

4 September 2017

1 reference

Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea

21 January 2018

1 reference

Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).

21 January 2018

1 reference

Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study

21 January 2018

1 reference

Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion

21 January 2018

1 reference

Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.

21 January 2018

1 reference

Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.

21 January 2018

1 reference

Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.

21 January 2018

1 reference

A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial

21 January 2018

1 reference

Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial

21 January 2018

1 reference

Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial

21 January 2018

1 reference

Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection: An Updated Systematic Review

21 January 2018

1 reference

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.

21 January 2018

1 reference

Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies

21 January 2018

1 reference

Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection

21 January 2018

1 reference

Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection

21 January 2018

1 reference

Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis

21 January 2018

1 reference

Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.

21 January 2018

1 reference

Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial

21 January 2018

1 reference

Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, Poland

21 January 2018

1 reference

Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.

21 January 2018

1 reference

The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America

21 January 2018

1 reference

Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients

21 January 2018

1 reference

Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany

21 January 2018

1 reference

Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans.

21 January 2018

1 reference

Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients

21 January 2018

1 reference

Helicobacter pylori antimicrobial resistance rates in the central region of Portugal.

21 January 2018

1 reference

Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat

21 January 2018

1 reference

The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece

21 January 2018

1 reference

High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam

21 January 2018

1 reference

Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection

21 January 2018

1 reference

A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.

21 January 2018

1 reference

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection

21 January 2018

1 reference

Efficacy of reduced-dose regimen of a capsule containing bismuth subcitrate, metronidazole, and tetracycline given with amoxicillin and esomeprazole in the treatment of Helicobacter Pylori infection

21 January 2018

1 reference

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.

21 January 2018

1 reference

Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study

21 January 2018

1 reference

Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis

21 January 2018

1 reference

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

21 January 2018

1 reference

Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy

21 January 2018

1 reference

Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea

21 January 2018

1 reference

Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice.

21 January 2018

1 reference

The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication

21 January 2018

1 reference

Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.

21 January 2018

1 reference

Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.

21 January 2018

1 reference

The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea

21 January 2018

1 reference

Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea

21 January 2018

1 reference

High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection

21 January 2018

1 reference

New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China

21 January 2018

1 reference

High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections

21 January 2018

1 reference

Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection.

21 January 2018

1 reference

Lactobacillus reuteri in the treatment of Helicobacter pylori infection

21 January 2018

1 reference

The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis

21 January 2018

1 reference

Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection

21 January 2018

1 reference

Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska

21 January 2018

1 reference

Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection

21 January 2018

1 reference

Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study

21 January 2018

1 reference

A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12258

1 reference

4 September 2017

1 reference

PubMed ID

26372826